Literature DB >> 8242071

Somatic mutations of the APC gene in precancerous lesion of the stomach.

S Nakatsuru1, A Yanagisawa, Y Furukawa, S Ichii, Y Kato, Y Nakamura, A Horii.   

Abstract

The adenomatous polyposis coli (APC) gene, responsible for familial adenomatous polyposis, is also associated with development of sporadic tumors in digestive system as colon, stomach, or pancreas. In order to investigate whether or not APC mutations occur as an early genetic event during gastric carcinogenesis, we examined somatic mutations of APC in flat adenomas of the stomach. DNAs isolated from flat adenomas were examined by means of an RNase protection analysis coupled with polymerase chain reaction (PCR) followed by DNA sequencing of the PCR products. By screening a mutation cluster region (MCR: codons between 1286 and 1513) of APC in which two-thirds of somatic mutations were detected in colorectal tumors, somatic mutations were found in four of ten flat adenomas: three of which caused truncation of the gene product due to a nonsense mutation or 4-bp deletion; one other was a point mutation that altered amino acid from alanine to threonine. Our results imply that APC plays a crucial role in an early step of gastric carcinogenesis, as was observed in colorectal carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8242071     DOI: 10.1093/hmg/2.9.1463

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  13 in total

1.  Clinicopathologic characteristics of colorectal cancer patients with synchronous and metachronous gastric cancer.

Authors:  Sang Nam Yoon; Sung Tae Oh; Seok-Byung Lim; Tae Won Kim; Jong Hoon Kim; Chang Sik Yu; Jin Cheon Kim
Journal:  World J Surg       Date:  2010-09       Impact factor: 3.352

Review 2.  Role of the Wnt/β-catenin pathway in gastric cancer: An in-depth literature review.

Authors:  Miguel Angel Chiurillo
Journal:  World J Exp Med       Date:  2015-05-20

3.  Tumor differentiation phenotype in gastric differentiated-type tumors and its relation to tumor invasion and genetic alterations.

Authors:  Kimiyasu Yamazaki; Yusuke Tajima; Reiko Makino; Nobukazu Nishino; Shigeo Aoki; Masanori Kato; Masaaki Sakamoto; Koji Morohara; Tsutomu Kaetsu; Mitsuo Kusano
Journal:  World J Gastroenterol       Date:  2006-06-28       Impact factor: 5.742

4.  Microsatellite instability in gastric intestinal metaplasia in patients with and without gastric cancer.

Authors:  W K Leung; J J Kim; J G Kim; D Y Graham; A R Sepulveda
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

5.  Mutation analysis of APC gene in gastric cancer with microsatellite instability.

Authors:  Dian-Chun Fang; Yuan-Hui Luo; Shi-Ming Yang; Xiao-An Li; Xian-Long Ling; Li Fang
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

Review 6.  Cellular and molecular aspects of gastric cancer.

Authors:  Malcolm-G Smith; Georgina-L Hold; Eiichi Tahara; Emad-M El-Omar
Journal:  World J Gastroenterol       Date:  2006-05-21       Impact factor: 5.742

7.  Inverse relationship between APC gene mutation in gastric adenomas and development of adenocarcinoma.

Authors:  Jae-Hyuk Lee; Susan C Abraham; Hyun-Soo Kim; Jong-Hee Nam; Chan Choi; Min-Cheol Lee; Chang-Soo Park; Sang-Woo Juhng; Asif Rashid; Stanley R Hamilton; Tsung-Teh Wu
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

8.  Helicobacter, Inflammation, and Gastric Cancer.

Authors:  Antonia R Sepulveda
Journal:  Curr Pathobiol Rep       Date:  2013-03

9.  Acute WNT signalling activation perturbs differentiation within the adult stomach and rapidly leads to tumour formation.

Authors:  S Radulescu; R A Ridgway; J Cordero; D Athineos; P Salgueiro; R Poulsom; J Neumann; A Jung; S Patel; J Woodgett; N Barker; D M Pritchard; K Oien; O J Sansom
Journal:  Oncogene       Date:  2012-06-04       Impact factor: 9.867

10.  Infrequent alterations of the APC and MCC genes in gastric cancers from British patients.

Authors:  R Sud; I C Talbot; J D Delhanty
Journal:  Br J Cancer       Date:  1996-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.